MIAME Home
 MIAME 1.1
 MIAME MAGE-OM
 MIAME Checklist
 MIAME Software
 MIAME Archive
 Nov 1999
 Apr 2000
 May 2000
 Nov 2000
 Mar 2001
 Jan 2002
 Mar 2002
 MIAME 1.0
 Miscellaneous
 Checklist
 Details
 Home  Meetings  Workgroups  Mission  MGED Board  Site Map

Home : Workgroups : MIAME : MIAME Archive : Nov 1999

Details of the minimum information

November 1999  - for archive purposes

The meeting accepted the items 1a) -c) and 2a) - i) by consensus. There were two general opinions about a more detailed specifications of each of the subitems. A clear majority considered the level of detail given in the bullets below is close to the minimum that has to be provided about any published experiment. Nevertheless, there were a considerable number of participants, who considered the proposed details excessive. It was agreed that the details will be specified by working groups and by e-mail discussion and proposed for discussion at a follow-up meeting.

Minimum information that has to be provided about a published microarray experiment:

  1. expression level measurement results, in particular:
    1. the TIFF image file from the hybridised microarray scanning;
    2. image analysis output (of the particular image analysis software that has been used) for each spot, for each channel;
    3. a derived value summarising each spot in the authors interpretation (such as background subtracted intensity of the spot typically used for Stanford or Incyte technologies);
  2. the following annotations:
    1. array
      • array name (e.g., "Stanford Human 10K set),
      • platform type: spotted vs. synthesized (spotted - oligos, PCR products, plasmids, colonies),
      • if commercial array,
        • provider
        • unique ID from the provider
      • array dimensions
      • spot dimensions
      • number of columns and rows, or number of spots
      • brief description
      • substrate
    2. each element (spot) on the array
      • sequence info (if known)
        • sequence accession number in EMBL (GenBank, DDBJ) if known
        • sequence itself (if databases do not contain it)
        • number of oligos and the reference sequence (or accession number) for Affymetrix chips, plus the oligo sequences, if given
      • clone info (obligatory, if sequence is not verified)
        • clone ID (plus clone provider and date) if sequence is not verified by the chip designer
        • quality information from the clone provider
      • checking of the DNA quality (none, resequenced, quality check by gel separation, amount of DNA)
      • if the element can be used for normalisation or control (e.g., element should have expected value)
    3. sample source and treatment: Note that some of these categories are relevant only in particular contexts. For instance, tissue is relevant only to multi-cellular organisms. The categories mentioned below should be considered as a tree-like structure, and depending on the particular path along the tree, only some of the specified categories become relevant.
      • cell source and type (if derived from primary sources (s))
        • organism (NCBI taxonomy)
        • sex
        • age
        • development stage
        • organism part (tissue)
        • animal/plant strain or line (if applicable)
          • genetic variation (gene knockout, transgenic variation)
        • individual (if applicable)
          • unique identifier for references in other hybridisations or overall experiment description
          • individual genetic characteristics (disease alleles, polymorphisms, etc.)
        • disease state (or normal)
        • target cell type
          • separation technique (none, trimming, microdissection, FACS, ...)
          • estimated % target
      • cell line and source (if applicable)
      • treatments
        • in vivo (organism or individual treatments)
        • in vitro treatments (cell culture conditions)
        • treatment type (e.g., small molecule, heat shock, cold shock, food deprivation, .)
        • compound
      • verbal description (laboratory protocol)
    4. controls
      • control type (prelabeled and added at hybridization [calibration of scan intensity to quantity]; added at sample labeling [quantitate sample labeling]; added at sample amplification [IVT or PCR control], ...)
      • ID for the controls
      • associated normalisation type array elements
    5. hybridisation extract preparation
      • reference to the respective extract preparation protocol, if exits in the database
      • cell rupture method
      • chemical extraction procedure
      • physical extraction procedure
      • whether total RNA, mRNA, or genomic is extracted
      • type of preselection
      • amount of nucleic acids extracted
      • target amplification (RNA polymerases, PCR)
      • which label is used (e.g., Cy3, Cy5, 33P)
      • the labelling ratio
      • laboratory protocol (free text)
    6. hybridisation procedure
      • reference to the respective hybridisation protocol, if already exits in the database
      • the solution (e.g., concentration of solutes)
      • blocking agent
      • wash procedure
      • time, concentration, volume, temperature
      • description of the hybridisation instruments
      • laboratory protocol (free text)
    7. scanning
      • reference to the respective scanning protocol, if already exits in the database
      • scanning hardware
      • scanning software
      • parsed header of the TIFF file, including laser power, spatial resolution, pixel space
      • laboratory protocol (free text)
    8. image analysis and quantitation
      • reference to the image analysis software or algorithm (including author, version)
      • relevant parameters
      • any normalisation that has been applied before the final output (was there a scalar adjustment of the measurements)
      • also, we would like to encourage the image analysis software developers to try to design methods for standard ways of summarising spot quality.
    9. experiment as a whole (i.e., set of related hybridisations)
      • author (submitter), data
      • platforms used;
      • comparative or absolute measurements,
      • single or multiple hybridisations,
      • single or multiple arrays,
      • For multiple hybridisations we have subtypes:
        • time course,
        • other ordered,
        • other unordered
        • relationship between samples (free text)
      • We can also classify the experiments by the type of the question that has been asked:
        • the aim of the experiment (free text) plus one of the following:
          • effect of gene knock-out
          • errect of gene knock-in (transgenics)
          • shock
          • dose response
          • normal vs. diseased comparison
          • treated vs. untreated comparison
          • other
      • brief description
      • quality related indicators
        • publication (if exists)
        • number of replicates

 

Home | Meetings | Workgroups | Mission | MGED Board | Site Map
 

Last modified: 26 Sep, 2005.                              Contact Us
This site is hosted by the EMBL -
European Bioinformatics Institute
The maintenance of these pages is partially supported by the European Commission as part of the
TEMBLOR project.
 

MGED Sponsors: